Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02048059 : ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases
PhasePhase 2
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

1. ? 18 years old

2. Breast cancer

3. Recurrent brain metastases from breast cancer

4. At least one radiologically-confirmed and measurable metastatic brain lesion ( ? 0.5
cm)

5. Neurologically stable

6. Karnofsky Performance Status (KPS) score ? 70

Exclusion Criteria:

1. Prior treatment with ANG1005/GRN1005

2. Pregnancy or lactation

3. Inadequate bone marrow reserve

4. Any evidence of severe or uncontrolled diseases

5. Patients with the presence of an infection including abscess or fistulae, or known
infection with hepatitis B or C or HIV

6. CNS disease requiring immediate neurosurgery intervention (e.g., resection, shunt
placement, etc.)

7. Known allergy to paclitaxel or any of its components
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02048059      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740